Allopurinol and the Risk of Diabetic Macular Edema among U.S. Veterans with Type 2 Diabetes.

S Scott Sutton Joseph MagagnoliTammy H CummingsJames W HardinJayakrishna Ambati

Published in: Ocular immunology and inflammation (2023)

Allopurinol could reduce the risk of DME, one of the major causes of visual disturbance among diabetic patients. Further research into the effects of allopurinol on DME is warranted.

Keyphrases